🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Although the notions that kidney transplantation is the treatment of choice...
Status
Withdrawn
Location
University of Illinois at Chicago
Start Date
2021-03-26
Trial ID
NCT04827186
Treatments Being Tested
The aim of this study is to induce a peptide-specific immune response in CL...
Status
Completed
Location
Katharinenhospital
Start Date
2016-10-05
Trial ID
NCT02802943
Treatments Being Tested
The study aims to assess the accuracy and impact of rapid diagnosis and rap...
Status
Completed
Location
Ålesund Hospital
Start Date
2017-09-01
Trial ID
NCT03256825
Treatments Being Tested
The prevalence of Multiple System Atrophy (MSA) is reported to be between 3...
Status
Unknown
Location
Cipto Mangunkusumo General Hospital
Start Date
2020-10-05
Trial ID
NCT04876326
Background: * Some cancers, such as Hodgkin's disease, anaplastic large ce...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2002-11-05
Trial ID
NCT00048880
Treatments Being Tested
RATIONALE: Collecting and storing samples of blood, urine, and tissue from ...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center - Cool Springs
Start Date
2007-01
Trial ID
NCT00900406
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT01139333
Treatments Being Tested
This is a prospective observational physiopathological study aimed at evalu...
Status
Recruiting
Location
AP-HP Laribosière Hospital, Anesthesia and Critical Care Departement
Start Date
2026-01
Trial ID
NCT07345169
RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in differ...
Status
Completed
Location
Aurora Presbyterian Hospital
Start Date
2008-01
Trial ID
NCT00521001
Treatments Being Tested
RATIONALE: ONTAK may be able to help reduce the type of cells that prevent ...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2005-09
Trial ID
NCT00425672